Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Vasc Surg. 2014 Apr 29;60(3):652–660. doi: 10.1016/j.jvs.2014.03.254

Table V. Major adverse cardiovascular events (MACE) occurring in 2 years after the procedure.

hsCRP BNP
Normal ≤0.80 mg/dL (n = 86) Abnormal/high >0.80 mg/dL (n = 32) P Normal ≤100 pg/mL (n = 94) Abnormal/high > 100 pg/mL (n = 24) P
Two years free from
 Myocardial infarction 99% 79% .004 93% 95% .884
 Stroke 94% 90% .672 96% 76% .032
 All-cause death 94% 82% .030 95% 72% .003

BNP, Brain natriuretic peptide; hsCRP, high-sensitivity C-reactive protein.